PHAGEinLYON Clinic Cohort Study: a Descriptive Study of Severe Infections Treated With Phage Therapy at the HCL.
NCT06185920 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 250
Last updated 2023-12-29
Summary
PHAGEinLYON Clinic cohort study is a single site non-interventional retrospective and prospective study, initiated by the Hospices Civils de Lyon. Population targeted are patients with a severe infection treated with bacteriophage in the Hospices civils de Lyon from 2015 to 2033. The primary objective is to describe the severe infections treated with phagotherapy. 250 patients will be included in the study.
Conditions
- Severe Infection
Interventions
- OTHER
-
Description of severe infection
Description of severe infections treated with bacteriophage in the Hospices Civils de Lyon from 2015 to 2033.
Sponsors & Collaborators
-
Hospices Civils de Lyon
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-02-01
- Primary Completion
- 2033-02-01
- Completion
- 2034-02-01
Countries
- France
Study Locations
More Related Trials
-
Biomarkers of Phage Treatment Response in NTM and Other Infections
NCT07076238 ·Status: RECRUITING
-
Bacteriophage Therapy for Mycobacterium Abscessus Pulmonary Infection
NCT07228702 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
Burden of Staphylococcus Lugdunensis Infections in Hospitalized Patients
NCT04318262 ·Status: UNKNOWN
-
French COVID Cohort
NCT04262921 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluation of Phage Therapy for the Treatment of Escherichia Coli and Pseudomonas Aeruginosa Wound Infections in Burned Patients
NCT02116010 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Phage Therapy for the Prevention and Treatment of Pressure Ulcers.
NCT04815798 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia
NCT04320615 ·Status: COMPLETED ·Phase: PHASE3
-
Phage Therapy for the Treatment of Urinary Tract Infection
NCT05537519 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
TOcilizumab and Covid-19 : Risk of Severe INfection
NCT05017441 ·Status: UNKNOWN
-
Study of the Nasal Intracellular Reservoir of Staphylococcus Aureus in Patients With S. Aureus Bacteremia
NCT06594250 ·Status: RECRUITING
-
Experimental Phage Therapy of Bacterial Infections
NCT00945087 ·Status: UNKNOWN ·Phase: NA
-
S. Aureus, Skin and Soft Tissue Infections
NCT02796742 ·Status: COMPLETED
-
Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis
NCT05177107 ·Status: TERMINATED ·Phase: PHASE2
-
Nosocomial Pneumonia With Suspected Or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)
NCT00084266 ·Status: COMPLETED ·Phase: PHASE4
-
ERAdicate S. Aureus in Patients With Bacteremia and Endocarditis
NCT05329168 ·Status: WITHDRAWN ·Phase: PHASE2
-
Combination Therapy With Fluoroquinolone in Staphylococcus Aureus Bacteremia
NCT00548002 ·Status: COMPLETED
-
Detection, Education, Research and Decolonization Without Isolation in Long-term Care Facilities
NCT01302210 ·Status: COMPLETED
-
Study of the Impact of a Targeted Decolonization of S. Aureus Persistent Carriers
NCT02945722 ·Status: TERMINATED ·Phase: PHASE4
-
Clinical Evaluation of the Residual Antimicrobial Activity
NCT04495920 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Therapeutic Drug Monitoring for Linezolid in the Treatment of Rifampin-resistant Tuberculosis
NCT06590428 ·Status: RECRUITING ·Phase: NA
-
Adjunctive Fosfomycin for Treatment of Staphylococcus Aureus Bacteraemia
NCT06695832 ·Status: ACTIVE_NOT_RECRUITING
-
The Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of BWC0977 in Healthy Adult Volunteers
NCT05942820 ·Status: TERMINATED ·Phase: PHASE1
-
Study of the Nasal Decolonisation of Staphylococcus Aureus (SA) and the Safety and Tolerability of XF-73 Nasal Gel in Healthy Subjects
NCT02282605 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
First-in-man Single-dose and Multiple Dose Study to Evaluate the Safety, Tolerability and Efficacy ofHY-133
NCT06290557 ·Status: RECRUITING ·Phase: PHASE1
-
Efficacy of Cloxacillin and Fosfomycin Combination Versus Cloxacillin Monotherapy in Patients With MSSA Bacteremia
NCT03959345 ·Status: TERMINATED ·Phase: PHASE4